Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Citation: Boominathan, L., Anti-metastasis therapy: Resistin inhibits epithelial-mesenchymal transition and HEF1 expression via up regulation of its target gene, 10/October/2014, 22.38, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Significance: This study suggests that tumor suppressor Resistin, by increasing the expression of its target gene, it may decrease the expression of EMT protein HEF1. Therefore, pharmacological formulations encompassing “Resistin activators“ may be used to treat metastatic cancers.